Cabio Biotech (Wuhan) Co., Ltd. (688089.SS) SHH

28.16

-1.21(-4.12%)

Updated at August 19 02:25PM

Currency In CNY

Valuation

Market Cap3.19B
Enterprise Value3.06B
P/E Ratio32.86
PEG Ratio1.87
Price/Sales Ratio8.06
Price/Book Ratio2.98
Enterprise/Revenue7.8
Enterprise/EBITDA29.14

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterMarch 31, 2025

Profitability

Profit Margin0.24
Operating Margin0.25

Management Effectiveness

Return On Assets0.08
Return On Equity0.09

Income Statement

Revenue555.59M
Revenue/Share3.57
Gross Profit242.32M
EBITDA196.9M
Net Income124.21M
Diluted EPS0.74

Balance Sheet

Total Cash207.97M
Total Cash/Share2.23
Total Debt52.29M
Total Debt/Equity0.03
Current Ratio7.46
Book Value Per Share9.66

Price History

52-Week Change87.71
52-Week High30.12
52-Week Low14.06
Moving Average 50 Days26.11
Moving Average 200 Days23.64

Statistics

Average Volume4.27M
Shares Outstanding167.75M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.2
Trailing Annual Dividend Yield0.7
Payout Ratio0.24
Last Split Factor7:5
Last Split DateJuly 18, 2023